Showing results (241-250 of 294) with videos related to
Sort By:
Pageof 30
Plos Pathogens|January 29, 2021
Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infectionsAdam T Waickman, Heather Friberg, Gregory D Gromowski, et al.Science Translational Medicine|October 26, 2022
Evolution of inflammation and immunity in a dengue virus 1 human infection modelAdam T Waickman, Joseph Q Lu, HengSheng Fang, et al.Nature Microbiology|December 19, 2023
Household immunity and individual risk of infection with dengue virus in a prospective, longitudinal cohort studyMarco Hamins-Puértolas, Darunee Buddhari, Henrik Salje, et al.Vaccine|March 12, 2018
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccinesKirsten S Vannice, Annelies Wilder-Smith, Alan D T Barrett, et al.Vaccine|September 11, 2019
Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseasesMarcia A Blackman, Mark A Marchionni, John Gilly, et al.BMC Biology|December 31, 2016
Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spreadIrina Maljkovic Berry, Melanie C Melendrez, Tao Li, et al.The American Journal of Tropical Medicine and Hygiene|March 14, 2008
Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive childrenSriluck Simasathien, Stephen J Thomas, Veerachai Watanaveeradej, et al.Journal of Virology|May 14, 2026
Longitudinal analysis of viral and host RNA in blood and saliva during controlled human dengue virus 3 infectionsSharon S Wu, Jennifer N Bjerke, Casey E Middleton, et al.The American Journal of Tropical Medicine and Hygiene|March 4, 2020
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I StudyClemente Diaz, Michael Koren, Leyi Lin, et al.The American Journal of Tropical Medicine and Hygiene|February 4, 2015
An adjuvanted, tetravalent dengue virus purified inactivated vaccine candidate induces long-lasting and protective antibody responses against dengue challenge in rhesus macaquesStefan Fernandez, Stephen J Thomas, Rafael De La Barrera, et al.Pageof 30